Erastin: Mechanism of Action

Erastin MOA:Targeting SLC7A11/Ferroptosis Pathway for Oncology

🎯 check Erastin product page

Erastin is a potent system Xc- inhibitor and ferroptosis inducer. It affects Nrf2/HO-1 and AMPK signaling pathways, by depleting intracellular glutathione, decreasing GPX4 activity, and promoting lipid peroxidation and ROS accumulation, to induce ferroptosis and inhibit cancer cell proliferation.

Primary Applications and Mechanism of Action